Latest news
Loading news…
Neuvivo
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Palo Alto, California, United States Founded 2020 11-50 employees For Profit
Neuvivo is a late clinical-stage biopharmaceutical company developing a new ALS treatment.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
4
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 19
- IT spend
- $81K
Company Info
- Founded
- 2020
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 18
- HQ
- Palo Alto, California, United States
- Region
- San Francisco Bay Area, Silicon Valley, West Coast
- Diversity spotlight
- Women Founded
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 1.9
- Trend (90d)
- -0.6
- Last leadership hire
- Jul 30, 2025
Key People at Neuvivo
Chief Medical Affairs Officer
Founder and CEO
CMO
4
professional contacts at Neuvivo
Contact execs at Neuvivo →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Neuvivo
Loading news…
FAQs about Neuvivo
People who checked this page also checked these
Browse the full Acquirezy directory.